Dr. Benjamin Herzberg, MD
Claim this profileNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
Studies Lung Cancer
Studies Cancer
6 reported clinical trials
9 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage IV
Stage I
2Cancer
Stage IV
Stage III
MTAP positive
Affiliated Hospitals
Clinical Trials Benjamin Herzberg, MD is currently running
LY4066434
for Solid Tumors
The main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combination with other treatments. The study will have 2 parts: monotherapy dose escalation and dose optimization. The study is expected to last up to approximately 5 years.
Recruiting1 award Phase 14 criteria
LY4050784
for Advanced Cancer
The main purpose of this study is to find out whether the study drug, LY4050784, is safe, tolerable and effective in participants with locally advanced or metastatic solid tumors with a BRG1 (Brahma-related gene 1, also known as SMARCA4) alteration who have previously received, do not qualify for, or are refusing standard of care treatments, or there is no standard therapy available for the disease. The study is conducted in two parts - phase Ia (dose-escalation) and phase Ib (dose-optimization, dose-expansion). The study will last up to approximately 4 years.
Recruiting1 award Phase 12 criteria
More about Benjamin Herzberg, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Benjamin Herzberg, MD has experience with
- IDE397
- Apricity C.A.R.E. Program For Cancer Adverse Events Rapid Evaluation
- Berzosertib
- Carboplatin
- Gemcitabine Hydrochloride
- Pembrolizumab
Breakdown of trials Benjamin Herzberg, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Herzberg, MD specialize in?
Benjamin Herzberg, MD focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Benjamin Herzberg, MD currently recruiting for clinical trials?
Yes, Benjamin Herzberg, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Benjamin Herzberg, MD has studied deeply?
Yes, Benjamin Herzberg, MD has studied treatments such as IDE397, Apricity C.A.R.E. Program for Cancer Adverse events Rapid Evaluation, Berzosertib.
What is the best way to schedule an appointment with Benjamin Herzberg, MD?
Apply for one of the trials that Benjamin Herzberg, MD is conducting.
What is the office address of Benjamin Herzberg, MD?
The office of Benjamin Herzberg, MD is located at: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York 10032 United States. This is the address for their practice at the NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.